← Back to Search

Wireless Ingestible Device

Vitals Monitoring Pill System for Sleep

N/A
Recruiting
Led By Justin Kupec, MD
Research Sponsored by Celero Systems, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during polysomnography
Awards & highlights

Study Summary

This trial will test a new pill that monitors respiration from within the gastrointestinal tract, and compare it to data from clinical sensors.

Who is the study for?
This trial is for healthy people between 18 and 65 years old who are already scheduled to have a sleep study called polysomnography. It's not suitable for those outside this age range or with health conditions that would exclude them from safely participating.Check my eligibility
What is being tested?
The trial is testing the Celero Vitals Monitoring Pill, an ingestible device designed to measure breathing rates from inside the gut. The results will be compared with standard clinical sensors used during polysomnography.See study design
What are the potential side effects?
Since it's a minimal risk study, side effects are expected to be very minor if any. However, potential risks may include discomfort swallowing the pill or mild gastrointestinal upset.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during polysomnography
This trial's timeline: 3 weeks for screening, Varies for treatment, and during polysomnography for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Calorimetry, Indirect

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients undergoing polysomnographyExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Celero Systems, Inc.Lead Sponsor
1 Previous Clinical Trials
10 Total Patients Enrolled
Justin Kupec, MDPrincipal InvestigatorWest Virginia University
Ali Rezai, MDPrincipal InvestigatorWest Virginia University
4 Previous Clinical Trials
14 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Sep 2024